403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Syria welcomes US Senate vote to repeal Caesar Act sanctions
(MENAFN) Syria has welcomed the US Senate’s vote to repeal the Caesar Act sanctions, describing it as a “positive development” that could open new opportunities for international cooperation. Syrian Foreign Minister Asaad al-Shaibani expressed gratitude to the Senate, saying the move supports the Syrian people and lays the groundwork for strengthened partnerships between Syria and the global community.
The repeal was included in the National Defense Authorization Act (NDAA) for fiscal year 2026, a $901 billion defense policy and spending bill. The Senate approved the measure 77–20, following earlier passage by the House of Representatives. The legislation now awaits President Donald Trump’s signature.
The Caesar Act, enacted in 2019 under the Assad regime, allowed the US to impose sanctions on individuals and entities, Syrian or foreign, that support Syria’s military, intelligence, aviation, or energy sectors, as well as those assisting the regime in obtaining goods, services, or technology for military use. Its repeal marks a significant shift in US policy toward Syria.
The repeal was included in the National Defense Authorization Act (NDAA) for fiscal year 2026, a $901 billion defense policy and spending bill. The Senate approved the measure 77–20, following earlier passage by the House of Representatives. The legislation now awaits President Donald Trump’s signature.
The Caesar Act, enacted in 2019 under the Assad regime, allowed the US to impose sanctions on individuals and entities, Syrian or foreign, that support Syria’s military, intelligence, aviation, or energy sectors, as well as those assisting the regime in obtaining goods, services, or technology for military use. Its repeal marks a significant shift in US policy toward Syria.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment